Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
UROGEN PHARMA LTD
About URGN
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
Find out what a historical investment in UROGEN PHARMA LTD would be worth today using our URGN stock calculator.
Market Capitalisation
$1.38B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
785.24K
High today
$30.32
Low today
$28.43
Open price
$28.78
52-week high
$32.37
52-week low
$3.42
Ready to start your investing journey with Stake?
Open an accountHow do I buy URGN shares in Australia?
Buying URGN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in UROGEN PHARMA LTD in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in URGN
What is the ticker symbol of UROGEN PHARMA LTD?
The ticker symbol for UROGEN PHARMA LTD is URGN.
How much is one share of URGN?
One share of URGN is valued at $30.14 as of 20 May 2026.
What is the market capitalisation of UROGEN PHARMA LTD URGN?
As of 20 May 2026 UROGEN PHARMA LTD has a market cap of $1.38B.
What is the 52-week high for UROGEN PHARMA LTD stock?
The UROGEN PHARMA LTD 52-week high stock price is $32.37.
What is the 52-week low for UROGEN PHARMA LTD stock?
The UROGEN PHARMA LTD 52-week low stock price is $3.42.
Can I buy URGN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy URGN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in URGN on Stake
- Buy URGN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of URGN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
URGN related stocks